Molecular Gene Technologies India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-01-2025
- Paid Up Capital ₹ 0.35 M
as on 02-01-2025
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -15.77%
(FY 2016)
- Profit 1205.99%
(FY 2016)
- Ebitda 201.10%
(FY 2016)
- Net Worth 59.24%
(FY 2016)
- Total Assets 37.34%
(FY 2016)
About Molecular Gene Technologies India
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Achyut Limaye and Nandakumar Hegganapalli serve as directors at the Company.
- CIN/LLPIN
U74140KA2004PTC034836
- Company No.
034836
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2004
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Molecular Gene Technologies India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandakumar Hegganapalli  | Director | 25-Jan-2007 | Current |
| Achyut Limaye | Director | 25-Jan-2007 | Current |
Financial Performance of Molecular Gene Technologies India.
Molecular Gene Technologies India Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 15.77% decrease. The company also saw a substantial improvement in profitability, with a 1205.99% increase in profit. The company's net worth Soared by an impressive increase of 59.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molecular Gene Technologies India?
In 2017, Molecular Gene Technologies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vibhava Marketing Corporation Private LimitedActive 1 year 4 monthsNandakumar Hegganapalli is a mutual person
Vibhava Industries Private LimitedActive 8 months 16 daysNandakumar Hegganapalli is a mutual person
- Saathi Steel Industries Private LimitedActive 18 years 10 months
Nandakumar Hegganapalli is a mutual person
- Ferro Fuetech Infra Private LimitedActive 1 year 3 months
Nandakumar Hegganapalli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Molecular Gene Technologies India?
Unlock and access historical data on people associated with Molecular Gene Technologies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molecular Gene Technologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Gene Technologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
